Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2021-04-07 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities for the month ended 31/3/2021. The content focuses on changes in the company's capital structure, including share issuance, repurchases, and other capital changes. There is no indication of financial performance data, management discussion, or audit information. The document is a regulatory filing reporting capital changes rather than a full financial report or announcement of a report. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement.
2021-04-07 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share repurchases, issued shares, and confirmations related to compliance with listing rules. The content focuses on share capital changes and repurchase activities, which aligns with announcements regarding share issues or capital changes. It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about capital changes and share repurchases. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (8357 characters) and detailed data confirm it is not a brief announcement or certification only, but a substantive disclosure of capital changes.
2021-04-01 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, CMBC Capital Holdings Limited, reporting changes in issued share capital and share buybacks. It includes detailed information on share repurchases, issued shares, and confirmations related to compliance with listing rules. The content focuses on disclosure of share capital changes and repurchase activities rather than financial performance, management discussion, or earnings. It is a regulatory disclosure related to capital changes and share buybacks, fitting the category of Transaction in Own Shares (POS). The document length (8006 characters) and detailed data support it being a substantive disclosure rather than a brief announcement or certification.
2021-03-30 English
NEXT DAY DISCLOSURE RETURN
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks by CMBC Capital Holdings Limited, submitted to the Stock Exchange of Hong Kong. It includes detailed information on share repurchases, number of shares issued, and confirmations regarding compliance with listing rules. The content focuses on capital changes and share repurchase activities rather than financial results, management commentary, or regulatory certifications. It is not an annual or interim report, earnings release, or management discussion. The document fits the description of a Share Issue/Capital Change announcement, as it reports on share capital changes and repurchases in compliance with listing rules.
2021-03-26 English
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report Classification · 100% confidence The document is titled 'ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020' and contains detailed consolidated financial statements including profit or loss, comprehensive income, financial position, segment information, and notes on accounting policies. It references the full fiscal year 2020 and comparative figures for 2019. The content includes extensive financial data, segment revenues, expenses, and notes consistent with a comprehensive annual financial report. The length of the document (15,000 characters) and the detailed financial disclosures confirm it is the full annual report rather than a brief announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2021-03-25 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding the date of a board meeting to consider and approve the consolidated annual results for the year ended 31 December 2020. It states that the board meeting will also consider the draft announcement of the annual results and a final dividend recommendation. The document is short (1663 characters) and does not contain any actual financial data or the full annual report itself. It is a notice about the timing of the board meeting and the upcoming results announcement, not the results or report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about the board meeting and upcoming results publication, rather than the Annual Report (10-K) or Earnings Release (ER).
2021-03-09 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.